IP is on the Advisory Board and receives research funding from for Incyte and Syndax; MV is on Speaker Bureau for KITE and has done the Advisory Board and Consulting for KITE, ADC therapeutics and Sanofi; CL is on the Advisory Board and Consulting for Incyte and Sanofi, she has received research funding form Incyte and is on Incyte Clinical Trial Steering Committee; CM has nothing to declare; JFD received research funding from Incyte, Mallinckrodt Pharmaceutical and he is on the Scientific Advisory Board for Magenta Therapeutics.